Skip to main content
Clinical Trials/NL-OMON48549
NL-OMON48549
Completed
Not Applicable

A non-therapeutic feasibility study to evaluate the kinetics and test-retest repeatability and reproducibility of the radioligand [11C]-UCB-J for imaging synaptic density in healthy subjects and mild-to-moderate Alzheimer*s Disease subjects - 170439 - RDN-NI-001

Rodin Therapeutics, Inc.0 sites20 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Alzheimer's Disease
Sponsor
Rodin Therapeutics, Inc.
Enrollment
20
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Healthy male or female age 50 \* 80 years old, inclusive, at the time of informed consent.;Group 2:
  • Adult males or females age 50 \* 80 years old, inclusive, at the time of informed consent.
  • Confirmed diagnosis of mild\-to\-moderate AD.

Exclusion Criteria

  • History or current evidence of any clinically significant cardiovascular, endocrinologic, hematologic, hepatobiliary, immunologic, metabolic, urologic, pulmonary, neurologic (with the exception of AD in Group 2\), psychiatric, renal, or other major disease, as determined by the Investigator.

Outcomes

Primary Outcomes

Not specified

Similar Trials